The longstanding research relationship between CWRU, primarily represented by the Case CFAR and the Case TBRU, the government of Uganda and Makerere University, has resulted in the development of an extensive research infrastructure in Uganda. CWRU was one of the first US academic institutions to move from """"""""safari"""""""" science to a strong integrated research approach involving teaching, training, and employment. We recently celebrated our twenty-year collaboration with the Ugandan government and Makerere University. Currently over 200 Ugandan scientists and health care professionals are actively involved in our collaborative programs. A major limitation to new initiatives in the developing world has been the lack of state-of-the-art laboratory facilities on site. The Case CFAR has fostered seminal studies on TB and HIV/AIDS by providing a state-of-the-art laboratories and facilities for clinical virology and molecular biology in Uganda. All the research laboratories (Virology/Molecular Biology, Immunology, Mycobacterial, and STD laboratories) are directed on site by Ugandans, all of whom have received advanced degrees from CWRU through the Fogarty AIDS Training Program. To further facilitate sharing of resources and to promote/support new research initiatives, all laboratory facilities and services associated with HIV/AIDS research are being administered by the Case CFAR Uganda Laboratory Core with the following two main Specific Aims: To provide comprehensive laboratory services to facilitate HIV/AIDS-related research projects of CFAR investigators To provide a mechanism for training of Ugandan scientists in collaboration with CWRU and Fogarty AIDS Training Grant.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036219-20
Application #
8641302
Study Section
Special Emphasis Panel (ZAI1-JBS-A)
Project Start
2014-05-01
Project End
2015-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
20
Fiscal Year
2014
Total Cost
$218,737
Indirect Cost
$75,740
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Belury, Martha A; Bowman, Emily; Gabriel, Janelle et al. (2017) Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV. Pathog Immun 2:376-403
Freeman, Michael L; Morris, Stephen R; Lederman, Michael M (2017) CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4+ T Cells. Pathog Immun 2:335-351
Athman, Jaffre J; Sande, Obondo J; Groft, Sarah G et al. (2017) Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation. J Immunol 198:2028-2037
Mukherjee, Pranab K; Chen, Huichao; Patton, Lauren L et al. (2017) Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. AIDS 31:81-88
Park, Michelle S; Hileman, Corrilynn O; Sattar, Abdus et al. (2017) Incidental findings on chest computed tomography are common and linked to inflammation in HIV-infected adults. Antivir Ther 22:127-133
Webel, Allison R; Perazzo, Joseph; Longenecker, Christopher T et al. (2017) The Influence of Exercise on Cardiovascular Health in Sedentary Adults With Human Immunodeficiency Virus. J Cardiovasc Nurs :
Hileman, Corrilynn O; Tangpricha, Vin; Sattar, Abdus et al. (2017) Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy. J Acquir Immune Defic Syndr 74:539-547
Stultz, Ryan D; Cenker, Jennifer J; McDonald, David (2017) Imaging HIV-1 Genomic DNA from Entry through Productive Infection. J Virol 91:
Karim, Ahmad F; Sande, Obondo J; Tomechko, Sara E et al. (2017) Proteomics and Network Analyses Reveal Inhibition of Akt-mTOR Signaling in CD4+ T Cells by Mycobacterium tuberculosis Mannose-Capped Lipoarabinomannan. Proteomics 17:
Fatukasi, Terra V; Cole, Stephen R; Moore, Richard D et al. (2017) Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients. PLoS One 12:e0180843

Showing the most recent 10 out of 500 publications